Seattle Washington - Washington D.C - Chicago - San Francisco Bay Area - Seattle SF Bay Area - New York City | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cloud Services (& Infrastructure) • Food & Beverage • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Robotics • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Investment Management • Consumer • Pharmaceutical (& Medicine) |
| Stages | Early,Seed, Series A, Series B |
| Investing | United States • Canada • Israel • Ireland |
| Investment Range | $50,000 - $50,000,000 |
| Investment Sweet Spot | $25,000,000 |
| Assets Under Management | $635,800,000 |
About The Fund
ARCH Venture Partners is an established venture capital firm with a focus on seeding and advancing early-stage technology companies across a wide array of industries. Since its inception in 1986, ARCH has been at the forefront of identifying and supporting disruptive companies at the intersection of information technology, life sciences, and physical sciences. With headquarters in Chicago, Illinois, ARCH manages a considerable portfolio consisting of companies that span sectors such as Software, IT & TMT, Media, BioTech, AgroTech, Business Solutions, FinTech & Financial services, Hardware & Manufacturing, Energy, CleanTech, A.I. & Big Data, HealthTech & Fitness, Cloud Services & Infrastructure, Food & Beverage, Logistics & Distribution, Material Science, Medical Devices & Hospital Services, Robotics, Aerospace & Defense, DeepTech, Healthcare & Wellness, Investment Management, Consumer, and Pharmaceutical & Medicine. The fund operates with an investment range from 50,000 USD to 150,000,000 USD, with a preferred 'sweet spot' for investments around 25,000,000 USD. ARCH is well-known for participating in various funding stages, including Early, Seed, Series A, and Series B rounds. They manage investments with assets under management amounting to approximately 635,800,000 USD. ARCH's approach to investment is deeply rooted in the idea of catalyzing discoveries that can prevent, detect, and cure diseases, leveraging great science and building strong teams. Their team looks for opportunities to drive growth in companies that have the potential to be transformative in their respective fields and work closely with entrepreneurs, offering advice, expertise, and access to a valuable network. The testimonials from CEOs and Chairs of companies in their portfolio highlight ARCH's commitment and unique ability to build dynamic and successful companies. ARCH's strategy and activities reflect their belief in the power of science and technology to provide groundbreaking solutions that address significant challenges and create lasting value.
ARCH Venture Partners's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
